Bacopa Monnieri · Bacopa monnieri
Ayurvedic memory herb with modest but real effects at 300 mg/day.
Short answer
Bacopa Monnieri (Bacopa monnieri) is a cognitive with evidence grade B, meaning it is supported by human RCTs. We track 2 produkter containing Bacopa Monnieri. Typical doses range from 300.0 to 450.0 mg per portion. The top-ranked product scores 8.1 out of 10 on our composite scale (dose, evidence, price, testing, transparency). Prices range up to $29.99 per månad.
Top Bacopa Monnieri produkter
| Product | Varumärke | Dose | Pris/mo | 3rd-party tested | Poäng |
|---|---|---|---|---|---|
| Bacognize Bacopa monnieri Capsules | 300.0 mg | $29.99 | Yes | 8.1 | |
| Bacopa Monnieri Extract Supplement | 450.0 mg | $17.95 | Yes | 7.5 |
Scores are editorial judgments, not a scientific standard. Se how we score.
What it is
An Ayurvedic wetland herb used for memory. Slow-acting, takes 8 to 12 weeks.
Why people take it
Meta-analyses show small but consistent memory improvements at 300 mg/day of standardised extract.
Our verdict
One of the better-studied nootropic herbs. Look for bacosides 45%+.
Structure & class
Bacosides A and B standardised.
Mechanism & clinical data
Kongkeaw 2014 metaanalys confirmed memory effects.
Pharmacokinetics
Chronic effect (~12 weeks).
Dose & forms
What to watch out for
Can cause GI upset. Take with food. Not for immediate results.
Where this dose comes from
The trial dose above is our editorial pick from the published human trials for this ingredient. We choose the dose that the best-available studies used on the endpoint most relevant to longevity. The range shows the lowest and highest doses tested in published trials. The landmark studies below are the papers we read to set it. You can click through and check our work.
When new trials publish, our automated sweeps flag them. If a new study materially changes the dose, we update it through editorial review and record the old dose, new dose, and the triggering study in every affected product's recommendation history. The dose is never changed automatically.
Regelverk status
Timeline
Regelverk events, evidence grade changes, and key research milestones for Bacopa Monnieri, most recent first. Every entry links to its primär source.
-
EU Court sharpens the bar for botanical health claimsA Court of Justice of the European Union ruling in april 2025 further tightened the requirements for how botanical ingredients (herbs, plant extracts) can be marketed with health claims in the EU, effectively removing much of the flexibility of the on-hold list.
-
EU report identifies 117 supplement substances as potential health risksThe HoA Working Group on Food Supplements (26 European countries) published its first report evaluating 117 substances used in food supplements. Of these, 65 were assessed as likely novel foods, 6 were already regulated, 34 had insufficient data, and 12 were prioritized for Article 8 restriction under Regulation (EC) No 1925/2006. The 12 priority substances include ashwagandha, curcumin, melatonin, piperine, St. John's wort, coumarin, p-synephrine, maca, holy basil, Melaleuca, black cohosh, and L-tryptophan. The report drew on 1,500 RASFF alerts reviewed between 2017 and mid-2022.
-
Pase et al. 2012 metaanalys (9 RCTs)A metaanalys of 9 RCTs (437 subjects) found Bacopa monnieri significantly improved cognition, particularly speed of attention, versus placebo.
-
Morgan & Stevens 2010 (memory RCT)In 98 healthy adults over 55, 12 weeks of Bacopa monnieri (300 mg/day) significantly improved verbal learning and delayed recall versus placebo, with mild GI side effects.
-
Calabrese et al. 2008 (elderly RCT)In a 54-person, 12-week RCT of adults 65+, Bacopa monnieri (300 mg/day) significantly improved delayed recall memory and Stroop task performance compared to placebo.
-
EU Health Claims Regulation adoptedRegulation (EC) No 1924/2006 laid down harmonised rules for nutrition and health claims made on foods, including supplements. Only claims listed in the EU Register of authorised claims can be used. Rejected botanical claims are held in a separate on-hold list.
-
EU introduces the Novel Food RegulationRegulation (EC) No 258/97 required any food or food ingredient without a history of consumption in the EU before 15 maj 1997 to be authorised before being placed on the market. This is the framework that captures NMN, spermidine as a supplement ingredient, urolithin A, and many other longevity actives.
Landmark studies
-
Calabrese et al. 2008 (elderly RCT)
In a 54-person, 12-week RCT of adults 65+, Bacopa monnieri (300 mg/day) significantly improved delayed recall memory and Stroop task performance compared to placebo.
Läs studie → -
Morgan & Stevens 2010 (memory RCT)
In 98 healthy adults over 55, 12 weeks of Bacopa monnieri (300 mg/day) significantly improved verbal learning and delayed recall versus placebo, with mild GI side effects.
Läs studie → -
Pase et al. 2012 metaanalys (9 RCTs)
A metaanalys of 9 RCTs (437 subjects) found Bacopa monnieri significantly improved cognition, particularly speed of attention, versus placebo.
Läs studie →
Found in these produkter (2)
Alla produkter in our catalog that contain Bacopa Monnieri, ranked by our overall score. Ranking is editorial, never paid.
Buying guides and comparisons
Related ingredients
Se alla in Cognitive →Molekyler in the same class, plus the actives most often formulated alongside Bacopa Monnieri in our catalogue.
Frequently asked questions
What is Bacopa Monnieri?
An Ayurvedic wetland herb used for memory. Slow-acting, takes 8 to 12 weeks.
What dose of Bacopa Monnieri should I take?
The trial dose in published human studies is 300 mg per dag, with a range of 300 to 600 mg per dag. Always consult a qualified clinician before starting any supplement.
Is Bacopa Monnieri safe?
Can cause GI upset. Take with food. Not for immediate results.
What is the best Bacopa Monnieri supplement?
We track 2 produkter containing Bacopa Monnieri. The top-ranked product scores 8.1 out of 10 on our composite scale, which evaluates dose, evidence, price, third-party testing, and transparency. See the comparison table above. Scores are editorial judgments, not a scientific standard.
What is the evidence grade for Bacopa Monnieri?
Bacopa Monnieri has evidence grade B, meaning it is supported by human RCTs. Grade A means replicated human RCTs with hard endpoints. Grade B means human RCTs with biomarker outcomes. Grade C means mixed or small human trials. See our evidence grading methodology.
Data verification
Bevisning grades are reviewed when new human RCTs are published. Product counts update automatically as new produkter are added. Dose ranges reflect published trial data, not brand recommendations. Read how we verify.